The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Apr. 19, 2016
Filed:
Jun. 25, 2010
Moon-hee Sung, Daejeon, KR;
Haryoung Poo, Daejeon, KR;
Chul Joong Kim, Daejeon, KR;
Young-ki Choi, Cheongju-si, KR;
Yong Taik Lim, Daejeon, KR;
Dong Jin Jeong, Daejeon, KR;
Sang-mu Shim, Daejeon, KR;
Moon-Hee Sung, Daejeon, KR;
Haryoung Poo, Daejeon, KR;
Chul Joong Kim, Daejeon, KR;
Young-Ki Choi, Cheongju-si, KR;
Yong Taik Lim, Daejeon, KR;
Dong Jin Jeong, Daejeon, KR;
Sang-Mu Shim, Daejeon, KR;
BIOLEADERS CORPORATION, Daejeon, KR;
KOOKMIN UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION, Seoul, KR;
KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY, Daejeon, KR;
THE INDUSTRY AND ACADEMIC COOPERATION IN CHUNGNAM NATIONAL UNIVERSITY, Daejeon, KR;
CHUNGBUK NATIONAL UNIVERSITY INDUSTRY ACADEMIC COOPERATION, Cheongju-si, Chungcheongbuk-do, KR;
Abstract
The present invention relates to an adjuvant composition containing poly-gamma-glutamic acid-chitosan nanoparticles and a vaccine composition containing the adjuvant composition, and more particularly to an adjuvant composition containing nanoparticles prepared by ionic bonding between poly-gamma-glutamic acid having ensured safety and chitosan, and a vaccine composition containing the poly-gamma-glutamic acid-chitosan nanoparticles and an antigen. The adjuvant containing the poly-gamma-glutamic acid-chitosan nanoparticles has little or no toxicity and side effects and is added to human or animal vaccines for the prevention and treatment of viral and bacterial infections and cancers to increase the production of antibodies.